Cable Hill Partners’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $279K | Buy |
+6,993
| New | +$279K | 0.03% | 154 |
|
2023
Q1 | – | Sell |
-6,834
| Closed | -$242K | – | 211 |
|
2022
Q4 | $242K | Buy |
+6,834
| New | +$242K | 0.04% | 169 |
|
2022
Q3 | – | Sell |
-5,710
| Closed | -$311K | – | 154 |
|
2022
Q2 | $311K | Buy |
+5,710
| New | +$311K | 0.08% | 104 |
|
2019
Q2 | – | Sell |
-1,777
| Closed | -$93K | – | 356 |
|
2019
Q1 | $93K | Sell |
1,777
-72
| -4% | -$3.77K | 0.03% | 180 |
|
2018
Q4 | $88K | Buy |
1,849
+1,680
| +994% | +$80K | 0.04% | 173 |
|
2018
Q3 | $8K | Hold |
169
| – | – | ﹤0.01% | 466 |
|
2018
Q2 | $9K | Hold |
169
| – | – | ﹤0.01% | 495 |
|
2018
Q1 | $8K | Hold |
169
| – | – | ﹤0.01% | 533 |
|
2017
Q4 | $8K | Sell |
169
-4,245
| -96% | -$201K | ﹤0.01% | 619 |
|
2017
Q3 | $224K | Buy |
4,414
+4,334
| +5,418% | +$220K | 0.1% | 83 |
|
2017
Q2 | $4K | Hold |
80
| – | – | ﹤0.01% | 593 |
|
2017
Q1 | $4K | Hold |
80
| – | – | ﹤0.01% | 576 |
|
2016
Q4 | $4K | Sell |
80
-325
| -80% | -$16.3K | ﹤0.01% | 581 |
|
2016
Q3 | $22K | Buy |
+405
| New | +$22K | 0.02% | 268 |
|
2015
Q2 | – | Sell |
-108
| Closed | -$6K | – | 739 |
|
2015
Q1 | $6K | Hold |
108
| – | – | ﹤0.01% | 528 |
|
2014
Q4 | $6K | Buy |
+108
| New | +$6K | 0.01% | 516 |
|